CNF Transition of Care Video Production

Posted on:

Transition of Care is the most diverse and comprehensive program at Child Neurology Foundation.  In late July, CNF worked with a director and film crew to shoot videos that would illuminate the complexity of transition of care for young adults living with neurologic conditions, their families, and the health care providers…  Read More

Help Improve Communication Around Epilepsy

Posted on:

Child Neurology Foundation is conducting a survey concerning knowledge and communication about epilepsy between medical professionals and families.  Results will be used to improve conversations about epilepsy.  Caregivers of people with epilepsy can complete the brief survey at: https://www.surveymonkey.com/r/CNF-2017  Read More

FDA Approves Eisai’s FYCOMPA® (perampanel) for Use as Monotherapy for the Treatment of Partial-Onset Seizures

Posted on:

   First antiepileptic drug (AED) to apply FDA’s regulatory pathway of extrapolation for monotherapy use; FDA proposed using this pathway to get monotherapy options to patients sooner    FYCOMPA has now treated more than 100,000 patients worldwide across different indications and formulations    Once-a-day FYCOMPA is the first and only…  Read More

Do You Know a Junior Leader?

Posted on:

Our partners at the Tuberous Sclerosis Alliance are now offering their 3rd annual TS Alliance Junior Leader Program. If you are a young adult affected by TSC, consider applying for the Junior Leader Program. Applications are due AUGUST 1, 2017. The Junior Leader Program includes a trip to Washington, DC to…  Read More

CNF 2017 Annual Educational Initiative: SUDEP

Posted on:

Each year, CNF selects a topic to be the focus of its child neurology community educational initiative. For 2017, CNF selected Sudden Unexplained Death in Epilepsy (SUDEP) in children. SUDEP is when a seemingly healthy person with epilepsy dies unexpectedly and no clear reason for the death can be determined. The risk…  Read More

Cerebral Palsy is a Diagnosis, Not a Destiny: NEW OFFERINGS

Posted on:

CCPM is on the Move Children’s Cerebral Palsy Movement (CCPM) executed a successful multi-institutional, multi-disciplinary scientific pilot study, involving boys & girls with CP that demonstrated improvements in both cognitive and physical function. As CCPM has gotten to meet and know more families impacted by CP, they have come to…  Read More

NEW INTERACTIVE GRAPHIC: Tools for Transitioning Young Adults with Neurologic Conditions

Posted on:

Led by CNF, the consensus statement, The Neurologist’s Role in Supporting Transition to Adult Health Care* was published in July 2016. The statement identifies 8 Common Principles for the neurology team to adapt and employ-supporting the medical transition of your with neurologic conditions. To move policy into practice-ideally resulting in successful transitions-the CNF…  Read More

Midazolam Nasal Spray (USL261) Phase 3 Trial Meets Primary Efficacy Endpoint In Patients With Seizure Clusters

Posted on:

CAMBRIDGE, England, April 26, 2017 /PRNewswire/ — Proximagen Limited (Proximagen) today announced that its pivotal Phase 3 trial of intranasal midazolam (USL261) for the rescue treatment of seizure clusters, met its primary efficacy endpoint in a top-level analysis of the data. Based on these findings, Proximagen will approach the U.S. Food…  Read More

Exciting advancement for adolescents living with migraines!

Posted on:

FDA Approves Expanded Indication for Qudexy® XR (topiramate) Extended-Release Capsules to Include Prophylaxis of Migraine Headache in Adults and Adolescents Molecule Most Prescribed by Neurologists for Migraine Prophylaxis Now Available in a Unique 24-hour Formulation MAPLE GROVE, Minn., March 30, 2017 /PRNewswire/ — Upsher-Smith Laboratories, Inc. (Upsher-Smith) today announced that…  Read More

Rare Neurological Disease Special Report

Posted on:

Neurology Reviews presents its third annual Rare Neurological Disease Special Report, a compendium of articles and information covering a wide range of rare neurologic diseases. CNF is committed to the awareness and education of these rare conditions as evidenced by its newly-convened RARE Child Neurology Workgroup – a collaborative workgroup with…  Read More